HMR mutations: genetic mutations linked to aggressive myelofibrosis and poor outcomes. Erythropoiesis-stimulating agents: drugs that stimulate red blood cell production, often used to treat anemia.
Medpage Today on MSN11mon
Genetics and Genetic Testing to Inform Myelofibrosis Clinical ManagementMost studies have shown that JAK2, MPL, and CALR are mutually exclusive and do not occur together. However, a few studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback